Maunjaro is famous for Eli Lilly’s obesity treatment.
It was announced that it reduces the risk of diabetes by 94% in overweight and obese adults with pre-diabetes.
Except for congenital type 1, there seems to be a definite cure for type 2.
https://investor.lilly.com/news-releases/news-release-details/tirzepatide-reduced-risk-developing-type-2-diabetes-94-adults